title: Infectious diseases. Deferring competition, global net closes in on SARS.
authors.forename: Martin
authors.initials: M
authors.lastname: Enserink
authors.forename: Gretchen
authors.initials: G
authors.lastname: Vogel
mesh_terms: D000818:Animals; D000914:Antibodies, Viral / Q000032:analysis; D000998:Antiviral Agents / Q000494:pharmacology; D021821:Communicable Diseases, Emerging / Q000175:diagnosis / Q000453:epidemiology / Q000821:virology*; D004196:Disease Outbreaks; D000882:Haplorhini; D006801:Humans; D007391:International Cooperation; D029121:Metapneumovirus / Q000302:isolation & purification / Q000472:pathogenicity; D008826:Microbial Sensitivity Tests; D011643:Publishing; D045473:Severe acute respiratory syndrome-related coronavirus / Q000187:drug effects / Q000276:immunology / Q000302:isolation & purification* / Q000472:pathogenicity; D045169:Severe Acute Respiratory Syndrome / Q000175:diagnosis / Q000453:epidemiology / Q000821:virology*; D014944:World Health Organization
chemical_list: D000914:Antibodies, Viral; D000998:Antiviral Agents